Associated tags: Health, Surgery, CBS, Neurosurgery, Pectus carinatum, ABC, Safety, Degenerative disease, Â, Northwell Health, Surgeon, Patient, Donald, CNN, FDA, Neuroanatomy, Human, Brain, Netflix, Radiology
Retrieved on:
Wednesday, October 13, 2021
Surgery,
Health,
Medical Devices,
Leadership,
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell,
Aneurysm,
Technology,
FOX,
Publication,
Hofstra University,
LinkedIn,
Lenox Hill Hospital,
Physician,
Health,
Radiology,
Netflix,
Brain,
Human,
FDA,
Multimedia,
Neuroanatomy,
CNN,
Donald,
Patient,
Surgeon,
Northwell Health,
Â,
CEO,
Degenerative disease,
Twitter,
Safety,
ABC,
Pectus carinatum,
Neurosurgery,
CBS,
Medical device Longeviti Neuro Solutions , developer of the first low-profile intracranial devices that meet the functional and reconstructive needs of brain surgery patients, has hired Dr. David Langer as chief medical officer.
Key Points:
- Longeviti Neuro Solutions , developer of the first low-profile intracranial devices that meet the functional and reconstructive needs of brain surgery patients, has hired Dr. David Langer as chief medical officer.
- View the full release here: https://www.businesswire.com/news/home/20211013005740/en/
Longeviti Welcomes Renowned Neurosurgeon, Leading Cerebral Expert, Dr. David Langer as New Chief Medical Officer (Photo: Business Wire)
The core of Longevitis approach has always been guided by our desire to improve the patient experience, said Jesse Christopher, CEO and co-founder of Longeviti.
- In addition to being an exceptional neurosurgeon, Dr. Langer is committed to innovation and bringing the highest quality technology to the operating room.
- We are extremely fortunate to be guided by Dr. Langer as we bring our sonolucent products to patients across the country.
Radiology,
Health,
Surgery,
Medical devices,
Medical specialties,
Medicine,
Surgical specialties,
Health care,
Neurosurgery,
Neuroimaging,
Medical ultrasound,
Aaron Cohen-Gadol,
Radiology,
Health,
Surgery,
Medical devices,
Medical specialties,
Medicine,
Surgical specialties,
Health care,
Neurosurgery,
Neuroimaging,
Medical ultrasound,
Aaron Cohen-Gadol Longeviti Neuro Solutions , a medtech company developing innovative solutions for complex brain surgery, today announced the launch of the Longeviti ClearFit Cover.
Key Points:
- Longeviti Neuro Solutions , a medtech company developing innovative solutions for complex brain surgery, today announced the launch of the Longeviti ClearFit Cover.
- The first-of-its-kind sonolucent ClearFit Cover is used to replace excised cranial bone following a neurosurgical procedure, enabling neurosurgeons to use ultrasound imaging to view neuroanatomy after brain surgery, and allowing long-term monitoring of their patients condition.
- Now, surgeons can use a Longeviti ClearFit Cover to repair the cranial void and serve as a neuroimaging diagnostic tool.
- Longevitis focus is to develop innovative solutions for complex brain surgery that return patients to anatomical normalcy.
Retrieved on:
Tuesday, February 9, 2021
Medical devices,
Health,
Surgery,
Clinical trials,
General Health,
Biotechnology,
Surgery,
Medicine,
Surgical specialties,
Prosthetics,
Medical specialties,
Otorhinolaryngology,
Implant,
Neurosurgery,
Oral and maxillofacial surgery,
Craniofacial surgery,
Breast implant,
Breast augmentation The results of the study, which were published in The Journal of Craniofacial Surgery , evaluated the safety and effectiveness of the InvisiShunt implant, and whether it could minimize complications.
Key Points:
- The results of the study, which were published in The Journal of Craniofacial Surgery , evaluated the safety and effectiveness of the InvisiShunt implant, and whether it could minimize complications.
- This study demonstrates that, in addition to its reconstructive benefits, the InvisiShunt is safe and effective in treating patients.
- InvisiShunt is a single-use, sterile implant manufactured in various shapes and sizes for different areas of the craniofacial skeleton.
- https://www.youtube.com/watch?v=gqe9k4mCkNQ&t=7s
Longeviti is advancing neurosurgery through the development of low-profile intracranial implants that address the functional and reconstructive needs of patients with neurological conditions.
Retrieved on:
Tuesday, January 26, 2021
Health,
FDA,
Medical devices,
Surgery,
General Health,
Clinical trials,
Biotechnology,
Medicine,
Medical specialties,
Prosthetics,
Surgery,
Breast surgery,
Biomedical engineering,
Implant,
Tissue engineering,
Plastic surgery,
Otorhinolaryngology,
Breast implant,
Breast augmentation Longeviti Neuro Solutions today announced a new 510(k) clearance by the U.S Food and Drug Administration (FDA) for the ClearFit implant that acknowledges the use of ultrasound in post-operative imaging.
Key Points:
- Longeviti Neuro Solutions today announced a new 510(k) clearance by the U.S Food and Drug Administration (FDA) for the ClearFit implant that acknowledges the use of ultrasound in post-operative imaging.
- The Longeviti ClearFit implant is a neuro reconstructive implant that surgeons use to reconstruct a patients cranium.
- It is our hope that with this new clearance from the FDA, more surgeons will leverage the ClearFit implant for the benefits to them and their patients.
- There is no other implant on the market that both reconstructs a patients skull, and has FDA clearance for post-operative imaging using ultrasound, said Jesse Christopher, co-founder and CEO, Longeviti.
